Opin vísindi

Systems biology as an emerging paradigm in transfusion medicine

Skoða venjulega færslu

dc.contributor Háskólinn í Reykjavík
dc.contributor Reykjavik University
dc.contributor.author Yurkovich, James
dc.contributor.author Bordbar, Aarash
dc.contributor.author Sigurjonsson, Olafur
dc.contributor.author Palsson, Bernhard O.
dc.date.accessioned 2019-10-23T15:39:30Z
dc.date.available 2019-10-23T15:39:30Z
dc.date.issued 2018-03-07
dc.identifier.citation Yurkovich, J. T., Bordbar, A., Sigurjónsson, Ó. E., & Palsson, B. O. (2018). Systems biology as an emerging paradigm in transfusion medicine. BMC Systems Biology, 12(1), 31. https://doi.org/10.1186/s12918-018-0558-x
dc.identifier.issn 1752-0509
dc.identifier.uri https://hdl.handle.net/20.500.11815/1312
dc.description.abstract Blood transfusions are an important part of modern medicine, delivering approximately 85 million blood units to patients annually. Recently, the field of transfusion medicine has started to benefit from the “omic” data revolution and corresponding systems biology analytics. The red blood cell is the simplest human cell, making it an accessible starting point for the application of systems biology approaches. In this review, we discuss how the use of systems biology has led to significant contributions in transfusion medicine, including the identification of three distinct metabolic states that define the baseline decay process of red blood cells during storage. We then describe how a series of perturbations to the standard storage conditions characterized the underlying metabolic phenotypes. Finally, we show how the analysis of high-dimensional data led to the identification of predictive biomarkers. The transfusion medicine community is in the early stages of a paradigm shift, moving away from the measurement of a handful of chosen variables to embracing systems biology and a cell-scale point of view.
dc.description.sponsorship This research was supported by the European Research Council (ERC 232816), the National Heart, Lung, and Blood Institute (NHLBI R43HL123074), and the Landspitali University Hospital Research Fund.
dc.format.extent 31
dc.language.iso en
dc.publisher Springer Nature
dc.relation.ispartofseries BMC Systems Biology;12(1)
dc.rights info:eu-repo/semantics/openAccess
dc.subject Modelling and Simulation
dc.subject Applied Mathematics
dc.subject Molecular Biology
dc.subject Structural Biology
dc.subject Computer Science Applications
dc.subject Systems biology
dc.subject Red blood cell
dc.subject Transfusion medicine
dc.subject Metabolism
dc.subject Storage lesion
dc.subject Líkanagerð
dc.subject Stærðfræði
dc.subject Sameindalíffræði
dc.subject Forrit
dc.subject Blóðkorn
dc.subject Blóðgjöf
dc.subject Lyf
dc.subject Efnaskipti
dc.title Systems biology as an emerging paradigm in transfusion medicine
dc.type info:eu-repo/semantics/article
dcterms.license © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated
dc.description.version Peer Reviewed
dc.identifier.doi 10.1186/s12918-018-0558-x
dc.relation.url http://link.springer.com/content/pdf/10.1186/s12918-018-0558-x.pdf
dc.contributor.school Tækni- og verkfræðideild (HR)
dc.contributor.school School of Science and Engineering (RU)


Skrár

Þetta verk birtist í eftirfarandi safni/söfnum:

Skoða venjulega færslu